Key Information For BHVN

  1. NYSE
  2. >
  3. BHVN
Ticker BHVN
Description Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.
Exchange NYSE
Industry Sector Healthcare
Last Trade Price $46.00
Previous Close $45.88
52-Week High $67.86
52-Week Low $36.69
IV Percentile 98th
IV Rank 88.24%
IV Skew Percentile 40th
IV Skew Directional Sentiment Neutral
50-Day Moving Avg. $52.30
200-Day Moving Avg. $48.82
10-Day Avg. Volume 1,170,986
20-Day Avg. Volume 1,290,550
30-Day Avg. Volume 1,133,410
3-Month Avg. Volume 926,749
EPS $-9.37
Next Earnings Date Est. March 4th, 2020
Outstanding Shares 57,071,000
Float 48,075,955
Market Capitalization $2,641,242,500
Employees 63
Minimum Tick $0.0001
Minimum Tick >= $1.00 $0.01
Security Type Stock
Currency USD
Information Updated February 22nd, 2020